InvestorsHub Logo
Followers 8
Posts 389
Boards Moderated 0
Alias Born 02/12/2009

Re: exwannabe post# 124091

Friday, 05/24/2013 4:05:03 PM

Friday, May 24, 2013 4:05:03 PM

Post# of 345969
ex,

I'm curious why you would even ask that question. I wouldn't think that you would pretend to not know the credentials of DR. Garnick so I'm left wondering why you would ask that question.

Is it just a setup for you to diminish his accomplishments and qualifications? Let's see where you take this.

In response to your question:

"During his 24-year career at that company [Genentech], he was responsible for 17 new product approvals, including most of the company's top selling monoclonal antibody therapeutics such as Rituxan, Herceptin, Avastin and Lucentis."

"Rob has an unparalleled track record in the biotechnology and pharmaceutical industry, having led the regulatory, quality and compliance strategy for developing many of the most successful monoclonal antibody therapeutics currently on the market representing multiple disease areas,"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News